<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35560516</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-313X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>49</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of immunogenetics</Title>
          <ISOAbbreviation>Int J Immunogenet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Differential distribution of vitamin D receptor (VDR) gene variants and its expression in systemic lupus erythematosus.</ArticleTitle>
        <Pagination>
          <StartPage>181</StartPage>
          <EndPage>192</EndPage>
          <MedlinePgn>181-192</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/iji.12576</ELocationID>
        <Abstract>
          <AbstractText>Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disorder that displays an important genetic background. Vitamin D<sub>3</sub> (VD<sub>3</sub> ) through its receptor (VDR) plays an important immunomodulatory role in autoimmune misbalance, being capable of modulating immune responses. Genetic alterations in VDR gene may contribute to an altered risk in SLE development and clinical manifestations. We investigated VDR SNPs (single nucleotide polymorphisms) frequencies in 128 SLE patients and 138 healthy controls (HC) and mRNA differential expression in 29 patients and 17 HC regarding SLE susceptibility as well as clinical features. We observed that rs11168268 G allele (OR = 1.55, p = .01) and G/G genotype (OR = 2.69, p = .008) were associated with increased SLE susceptibility. The rs2248098 G allele and A/G and G/G genotypes were associated to lower SLE susceptibility (OR = 0.66, p = .01; OR = 0.46, p = .01; OR = 0.44, p = .02, respectively). Regarding clinical features, we observed lower risk for: rs11168268 A/G genotype and nephritis (OR = 0.31, p = .01); rs4760648 T/T genotype and photosensitivity (OR = 0.24, p = .02); rs1540339 T/T genotype and antibody anti-dsDNA (OR = 0.19, p = .015); rs3890733 T/T genotype and serositis (OR = 0.10, p = .01). We identified a significant downregulation in VDR expression levels when compared patients and controls overall (p = 1.04e<sup>-7</sup> ), in Cdx-2 A/G and G/G (p = .008 and p = .014, respectively) and in patients with nephritis (p = .016) Our results suggested that VDR SNPs influence upon SLE susceptibility and in particular clinical features, acting on mRNA expression in SLE patients overall and the ones with nephritis.</AbstractText>
          <CopyrightInformation>© 2022 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>De Azevêdo Silva</LastName>
            <ForeName>Jaqueline</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0003-1660-7299</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Genética, Universidade Federal de Pernambuco, Recife, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Lima</LastName>
            <ForeName>Suelen Cristina</ForeName>
            <Initials>SC</Initials>
            <Identifier Source="ORCID">0000-0003-3793-5152</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratório de Imunopatologia Keizo Asami, Universidade Federal de Pernambuco, Recife, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fragoso</LastName>
            <ForeName>Thiago Sotero</ForeName>
            <Initials>TS</Initials>
            <Identifier Source="ORCID">0000-0002-0192-0760</Identifier>
            <AffiliationInfo>
              <Affiliation>Serviço de Reumatologia do Hospital das Clínicas, Universidade Federal de Alagoas, Maceió, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cavalcanti</LastName>
            <ForeName>Catarina Addobbati Jordão</ForeName>
            <Initials>CAJ</Initials>
            <Identifier Source="ORCID">0000-0001-6598-0482</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Genética, Universidade Federal de Pernambuco, Recife, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barbosa</LastName>
            <ForeName>Alexandre Domingues</ForeName>
            <Initials>AD</Initials>
            <Identifier Source="ORCID">0000-0002-8055-0509</Identifier>
            <AffiliationInfo>
              <Affiliation>Ambulatório de Reumatologia do Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Borborema</LastName>
            <ForeName>Maria Eduarda de Albuquerque</ForeName>
            <Initials>MEA</Initials>
            <Identifier Source="ORCID">0000-0002-6692-3356</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratório de Genética e Biologia Molecular Humana, Departamento de Genética, Universidade Federal de Pernambuco, Recife, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Lucena</LastName>
            <ForeName>Thays Maria Costa</ForeName>
            <Initials>TMC</Initials>
            <Identifier Source="ORCID">0000-0002-1923-5833</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratório de Genética e Biologia Molecular Humana, Departamento de Genética, Universidade Federal de Pernambuco, Recife, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Duarte</LastName>
            <ForeName>Angela Luzia Branco Pinto</ForeName>
            <Initials>ALBP</Initials>
            <Identifier Source="ORCID">0000-0001-6434-9939</Identifier>
            <AffiliationInfo>
              <Affiliation>Ambulatório de Reumatologia do Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crovella</LastName>
            <ForeName>Sergio</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-8493-1168</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological and Environmental Sciences, College of Arts and Sciences, Qatar University, Doha, State of Qatar.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sandrin-Garcia</LastName>
            <ForeName>Paula</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0003-4641-7429</Identifier>
            <AffiliationInfo>
              <Affiliation>Departamento de Genética / Laboratório de Imunopatologia Keizo Asami, Universidade Federal de Pernambuco, Recife, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Immunogenet</MedlineTA>
        <NlmUniqueID>101232337</NlmUniqueID>
        <ISSNLinking>1744-3121</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018167">Receptors, Calcitriol</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C579457">VDR protein, human</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009393" MajorTopicYN="Y">Nephritis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018167" MajorTopicYN="N">Receptors, Calcitriol</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">SLE</Keyword>
        <Keyword MajorTopicYN="N">VDR</Keyword>
        <Keyword MajorTopicYN="N">genetic variants</Keyword>
        <Keyword MajorTopicYN="N">nephritis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>19</Hour>
          <Minute>6</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35560516</ArticleId>
        <ArticleId IdType="doi">10.1111/iji.12576</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Almaani, S., Meara, A., &amp; Rovin, B. H. (2017). Update on lupus nephritis. Clinical Journal of the American Society of Nephrology, 12(5), 825-835. https://doi.org/10.2215/CJN.05780616</Citation>
        </Reference>
        <Reference>
          <Citation>Anders, H. - J., Saxena, R., Zhao, M., Parodis, I., Salmon, J. E., &amp; Mohan, C. (2020). Lupus nephritis. Nature Reviews Disease Primers, 6(1), 7. https://doi.org/10.1038/s41572-019-0141-9</Citation>
        </Reference>
        <Reference>
          <Citation>Andress, D. L. (2006). Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation. Kidney International, 69(1), 33-43. https://doi.org/10.1038/sj.ki.5000045</Citation>
        </Reference>
        <Reference>
          <Citation>Bijl, M., &amp; Kallenberg, C. G. (2006). Ultraviolet light and cutaneous lupus. Lupus, 15(11), 724-727. https://doi.org/10.1177/0961203306071705</Citation>
        </Reference>
        <Reference>
          <Citation>Carvalho, C., Marinho, A., Leal, B., Bettencourt, A., Boleixa, D., Almeida, I., Farinha, F., Costa, P. P., Vasconcelos, C., &amp; Silva, B. M. (2015). Association between vitamin D receptor ( VDR ) gene polymorphisms and systemic lupus erythematosus in Portuguese patients. Lupus, 24(8), 846-853. https://doi.org/10.1177/0961203314566636</Citation>
        </Reference>
        <Reference>
          <Citation>Cavalcanti, C. A. J., De Azevêdo Silva, J., De Barros Pita, W., Veit, T. D., Monticielo, O. A., Xavier, R. M., Brenol, J. C. T., Brenol, C. V., Fragoso, T. S., Barbosa, A. D., Duarte, Â. L. B. P., Oliveira, R. D. R., Louzada-Júnior, P., Donadi, E. A., Crovella, S., Chies, J. A. B., &amp; Sandrin-Garcia, P. (2016). Vitamin D receptor polymorphisms and expression profile in rheumatoid arthritis brazilian patients. Molecular Biology Reports, 43(1), 41-51. https://doi.org/10.1007/s11033-015-3937-z</Citation>
        </Reference>
        <Reference>
          <Citation>Chen, S., Sims, G. P., Chen, X. X., Gu, Y. Y., Chen, S., &amp; Lipsky, P. E. (2007). Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. The Journal of Immunology, 179(3), 1634-1647. https://doi.org/10.4049/jimmunol.179.3.1634</Citation>
        </Reference>
        <Reference>
          <Citation>Correa-Rodríguez, M., Pocovi-Gerardino, G., Callejas-Rubio, J. -L., Ríos-Fernández, R., Martín-Amada, M., Cruz-Caparrós, M. -G., DelOlmo-Romero, S., Ortego-Centeno, N., &amp; Rueda-Medina, B. (2021). Vitamin D levels are associated with disease activity and damage accrual in systemic lupus erythematosus patients. Biological Research for Nursing, 23(3), 455-463. https://doi.org/10.1177/1099800420983596</Citation>
        </Reference>
        <Reference>
          <Citation>Di Rosa, M., Malaguarnera, M., Nicoletti, F., &amp; Malaguarnera, L. (2011). Vitamin D3: A helpful immuno-modulator. Immunology, 134(2), 123-139. https://doi.org/10.1111/j.1365-2567.2011.03482.x</Citation>
        </Reference>
        <Reference>
          <Citation>Dzhebir, G., Kamenarska, Z., Hristova, M., Savov, A., Vinkov, A., Kaneva, R., Mitev, V., &amp; Dourmishev, L. (2016). Association of vitamin D receptor gene BsmI B/b and FokI F/f polymorphisms with adult dermatomyositis and systemic lupus erythematosus. International Journal of Dermatology, 55(8), e465-e468. https://doi.org/10.1111/ijd.13263</Citation>
        </Reference>
        <Reference>
          <Citation>Eloi, M., Horvath, D. V., Ortega, J. C., Prado, M. S., Andrade, L. E. C., Szejnfeld, V. L., &amp; de Moura Castro, C. H. (2017). 25-Hydroxivitamin D serum concentration, not free and bioavailable vitamin D, is associated with disease activity in systemic lupus erythematosus patients. PLoS One, 12(1), e0170323. https://doi.org/10.1371/journal.pone.0170323</Citation>
        </Reference>
        <Reference>
          <Citation>Emerah, A. A., &amp; El-Shal, A. S. (2013). Role of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D level in Egyptian female patients with systemic lupus erythematosus. Molecular Biology Reports, 40(11), 6151-6162. https://doi.org/10.1007/s11033-013-2726-9</Citation>
        </Reference>
        <Reference>
          <Citation>Healy, K. D., Frahm, M. A., &amp; DeLuca, H. F. (2005). 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization. Archives of Biochemistry and Biophysics, 433(2), 466-473. https://doi.org/10.1016/j.abb.2004.10.001</Citation>
        </Reference>
        <Reference>
          <Citation>Healy, K. D., Zella, J. B., Prahl, J. M., &amp; DeLuca, H. F. (2003). Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium. Proceedings of the National Academy of Sciences, 100(17), 9733-9737. https://doi.org/10.1073/pnas.1633774100</Citation>
        </Reference>
        <Reference>
          <Citation>Huang, C. -M., Wu, M. -C., Wu, J. -Y., &amp; Tsai, F. -J. (2002). Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus, 11(1), 31-34. https://doi.org/10.1191/0961203302lu143oa</Citation>
        </Reference>
        <Reference>
          <Citation>Iruretagoyena, M., Hirigoyen, D., Naves, R., &amp; Burgos, P. I. (2015). Immune response modulation by Vitamin D: Role in systemic lupus erythematosus. Frontiers in Immunology, 6, 1-7. https://doi.org/10.3389/fimmu.2015.00513</Citation>
        </Reference>
        <Reference>
          <Citation>Jolliffe, D. A., Greiller, C. L., Mein, C. A., Hoti, M., Bakhsoliani, E., Telcian, A. G., Simpson, A., Barnes, N. C., Curtin, J. A., Custovic, A., Johnston, S. L., Griffiths, C. J., Walton, R. T., &amp; Martineau, A. R. (2018). Vitamin D receptor genotype influences risk of upper respiratory infection. British Journal of Nutrition, 120(8), 891-900. https://doi.org/10.1017/S000711451800209X</Citation>
        </Reference>
        <Reference>
          <Citation>Kamen, D. L., Cooper, G. S., Bouali, H., Shaftman, S. R., Hollis, B. W., &amp; Gilkeson, G. S. (2006). Vitamin D deficiency in systemic lupus erythematosus. Autoimmunity Reviews, 5(2), 114-117. https://doi.org/10.1016/j.autrev.2005.05.009</Citation>
        </Reference>
        <Reference>
          <Citation>Kamen, D. L., &amp; Tangpricha, V. (2010). Vitamin D and molecular actions on the immune system: Modulation of innate and autoimmunity. Journal of Molecular Medicine, 88(5), 441-450. https://doi.org/10.1007/s00109-010-0590-9</Citation>
        </Reference>
        <Reference>
          <Citation>Kim, A., &amp; Chong, B. F. (2013). Photosensitivity in cutaneous lupus erythematosus. Photodermatology, Photoimmunology &amp; Photomedicine, 29(1), 4-11. https://doi.org/10.1111/phpp.12018</Citation>
        </Reference>
        <Reference>
          <Citation>Klein, R., Moghadam-Kia, S., Taylor, L., Coley, C., Okawa, J., LoMonico, J., Chren, M. - M., &amp; Werth, V. P. (2011). Quality of life in cutaneous lupus erythematosus. Journal of the American Academy of Dermatology, 64(5), 849-858. https://doi.org/10.1016/j.jaad.2010.02.008</Citation>
        </Reference>
        <Reference>
          <Citation>Liang, Y., Leng, R. - X., Pan, H. - F., &amp; Ye, D. - Q. (2017). The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: A cross-sectional study. Rheumatology International, 37(2), 305-311. https://doi.org/10.1007/s00296-016-3630-0</Citation>
        </Reference>
        <Reference>
          <Citation>Livak, K. J., &amp; Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and. Methods (San Diego, Calif.), 25, 402-408. https://doi.org/10.1006/meth.2001.1262</Citation>
        </Reference>
        <Reference>
          <Citation>Luo, X., Wu, L., Yang, M., Liu, N., Liao, T., Tang, Z., Zeng, X. - F., &amp; Yuan, G. (2011). Relationship of vitamin D receptor gene Fok I polymorphism with systemic lupus erythematosus. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology, 27(8), 901-905. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21806892</Citation>
        </Reference>
        <Reference>
          <Citation>Luo, X. Y., Wu, L. J., Chen, L., Yang, M. H., Liao, T., Liu, N. T., &amp; Zhao, Y. (2012). The association of vitamin D receptor gene ApaI and BsmI polymorphism with systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi [Chinese Journal of Internal Medicine], 51(2), 131-135. https://doi.org/10.1016/j.atherosclerosis.2015.12.030</Citation>
        </Reference>
        <Reference>
          <Citation>Luo, X. -Y., Yang, M. -H., Wu, F. -X., Wu, L. -J., Chen, L., Tang, Z., Liu, N. -T., Zeng, X. -F., Guan, J. -L., &amp; Yuan, G. -H. (2012). Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus, 21(1), 53-59. https://doi.org/10.1177/0961203311422709</Citation>
        </Reference>
        <Reference>
          <Citation>Hochberg, M. C. (1997). Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 40(9), 1725.</Citation>
        </Reference>
        <Reference>
          <Citation>Mok, C., Birmingham, D., Ho, L., Hebert, L., Song, H., &amp; Rovin, B. (2012). Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: A comparison with anti-dsDNA and anti-C1q. Lupus, 21(1), 36-42. https://doi.org/10.1177/0961203311422094</Citation>
        </Reference>
        <Reference>
          <Citation>Mok, C. C., &amp; Lau, C. S. (2003). Pathogenesis of systemic lupus erythematosus. Journal of Clinical Pathology, 56(7), 481-490. https://doi.org/10.1016/j.jaut.2011.05.004</Citation>
        </Reference>
        <Reference>
          <Citation>Monticielo, O. A., Teixeira, T. D. M., Chies, J. A. B., Brenol, J. C. T., &amp; Xavier, R. M. (2012). Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus. Clinical Rheumatology, 25, . https://doi.org/10.1007/s10067-012-2021-5</Citation>
        </Reference>
        <Reference>
          <Citation>Mostowska, A., Lianeri, M., Wudarski, M., Olesińska, M., &amp; Jagodziński, P. P. (2013). Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Molecular Biology Reports, 40(2), 803-810. https://doi.org/10.1007/s11033-012-2118-6</Citation>
        </Reference>
        <Reference>
          <Citation>Ozaki, Y., Nomura, S., Nagahama, M., Yoshimura, C., Kagawa, H., &amp; Fukuhara, S. (2000). Vitamin-D receptor genotype and renal disorder in japanese patients with systemic lupus erythematosus. Nephron, 85(1), 86-91. https://doi.org/10.1159/000045635</Citation>
        </Reference>
        <Reference>
          <Citation>Ralston, A., &amp; Rossant, J. (2008). Cdx2 acts downstream of cell polarization to cell-autonomously promote trophectoderm fate in the early mouse embryo. Developmental Biology, 313(2), 614-629. https://doi.org/10.1016/j.ydbio.2007.10.054</Citation>
        </Reference>
        <Reference>
          <Citation>Salimi, S., Eskandari, F., Rezaei, M., &amp; Sandoughi, M. (2019). Vitamin D receptor rs2228570 and rs731236 polymorphisms are susceptible factors for systemic lupus erythematosus. Advanced Biomedical Research, 8(1), 48. https://doi.org/10.4103/abr.abr_19_19</Citation>
        </Reference>
        <Reference>
          <Citation>Savory, J. G. A., Bouchard, N., Pierre, V., Rijli, F. M., De Repentigny, Y., Kothary, R., &amp; Lohnes, D. (2009). Cdx2 regulation of posterior development through non-Hox targets. Development (Cambridge, England), 136, 4099-4110. https://doi.org/10.1242/dev.041582</Citation>
        </Reference>
        <Reference>
          <Citation>Silva, J. D. A., Fernandes, K. M., Pancotto, J. T., Fragoso, T. S., Donadi, E., Crovella, S., &amp; Sandrin-Garcia, P. (2013). Vitamin D receptor (VDR) gene polymorphisms and susceptibility to systemic lupus erythematosus clinical manifestations. Lupus, 21(1), 1110-1117. https://doi.org/10.1177/0961203313500549</Citation>
        </Reference>
        <Reference>
          <Citation>Sociedade Brasileira de Reumatologia. (2020). Lúpus Eritematoso Sistêmico (LES). Retrieved December 6, 2021, from https://www.reumatologia.org.br/doencas-reumaticas/lupus-eritematoso-sistemico-les/</Citation>
        </Reference>
        <Reference>
          <Citation>Stram, D. O. (2004). Tag SNP selection for association studies. Genetic Epidemiology, 27(4), 365-374. https://doi.org/10.1002/gepi.20028</Citation>
        </Reference>
        <Reference>
          <Citation>Sumethkul, K., Boonyaratavej, S., Kitumnuaypong, T., Angthararuk, S., Cheewasat, P., Manadee, N., &amp; Sumethkul, V. (2013). AB0682 Lupus nephritis is a significant predictor of vitamin D deficiency in SLE patients. Annals of the Rheumatic Diseases, 71(Suppl 3), 677.14-677. https://doi.org/10.1136/annrheumdis-2012-eular.682</Citation>
        </Reference>
        <Reference>
          <Citation>Tang, Y., Qin, W., Peng, W., &amp; Tao, Y. (2017). Development and validation of a prediction score system in lupus nephritis. Medicine, 93(37), e8024.</Citation>
        </Reference>
        <Reference>
          <Citation>Tsokos, G. C. (2011). Systemic lupus erythematosus. The New England Journal of Medicine, 365(22), 2110-2121. https://doi.org/10.1056/NEJMra1100359</Citation>
        </Reference>
        <Reference>
          <Citation>Uitterlinden, A. G., Fang, Y., van Meurs, J. B. J., Pols, H. A. P., &amp; van Leeuwen, J. P. T. M. (2004). Genetics and biology of vitamin D receptor polymorphisms. Gene, 338(2), 143-156. https://doi.org/10.1016/j.gene.2004.05.014</Citation>
        </Reference>
        <Reference>
          <Citation>Veldurthy, V., Wei, R., Oz, L., Dhawan, P., Jeon, Y. H., &amp; Christakos, S. (2016). Vitamin D, calcium homeostasis and aging. Bone Research, 4, 16041. https://doi.org/10.1038/boneres.2016.41</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, Y., Zhu, J., &amp; DeLuca, H. F. (2012). Where is the vitamin D receptor? Archives of Biochemistry and Biophysics, 523(1), 123-133. https://doi.org/10.1016/j.abb.2012.04.001</Citation>
        </Reference>
        <Reference>
          <Citation>Wöbke, T. K., Sorg, B. L., &amp; Steinhilber, D. (2014). Vitamin D in inflammatory diseases. Frontiers in Physiology, 5, 1-20. https://doi.org/10.3389/fphys.2014.00244</Citation>
        </Reference>
        <Reference>
          <Citation>Xiao, X., Wang, Y., Hou, Y., Han, F., Ren, J., &amp; Hu, Z. (2016). Vitamin D deficiency and related risk factors in patients with diabetic nephropathy. Journal of International Medical Research, 44(3), 673-684. https://doi.org/10.1177/0300060515593765</Citation>
        </Reference>
        <Reference>
          <Citation>Yan, S., Zheng, C., Chen, Z., Liu, R., Li, G., Hu, W., Pei, H., &amp; Li, B. (2012). Expression of endoplasmic reticulum stress-related factors in the retinas of diabetic rats. Experimental Diabetes Research, 2012, 1-11. https://doi.org/10.1155/2012/743780</Citation>
        </Reference>
        <Reference>
          <Citation>Yu, Q., Qiao, Y., Liu, D., Liu, F., Gao, C., Duan, J., Liang, L., Di, X., Yuan, Y., Gao, Y., Cui, S., Qin, Y., Li, T., Zheng, Z., &amp; Liu, Z. (2019). Vitamin D protects podocytes from autoantibodies induced injury in lupus nephritis by reducing aberrant autophagy. Arthritis Research &amp; Therapy, 21(1), 19. https://doi.org/10.1186/s13075-018-1803-9</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
